Why Do Two Athletes on the Same Program Get Such Different Results?
Have you ever trained side by side with someone for months — following the same program, eating similarly, sleeping comparable hours — and still seen completely different results? While one person turns every set of bench presses into visibly new centimeters of chest, the other seems to plateau for weeks on end. This frustrating disparity has a profound explanation: genetics.
Muscle hypertrophy — the process by which muscle fibers increase in diameter in response to mechanical stress — is not simply an equation of training plus nutrition. It is a complex biological process regulated by dozens of genes that control everything from anabolic hormone secretion to the sensitivity of muscle fibers to growth signals. Variants in these genes create substantial differences in each individual's capacity to build muscle mass.
Understanding the genetic basis of hypertrophy is not merely academically interesting: it is information that can transform how you train, how you eat, and how you set realistic expectations for your physical progress.
Scientific finding: Studies with identical twins demonstrate that the heritability of skeletal muscle mass lies between 50% and 80% — meaning more than half of the variation in muscle gain between individuals has a genetic origin, not just effort or diet.
The Core Genes of Muscle Hypertrophy
MSTN — The Myostatin Gene: The Brake on Muscle Growth
The MSTN gene encodes myostatin, a protein from the TGF-β (transforming growth factor beta) family that acts as a potent inhibitor of muscle growth. Myostatin is produced by the muscles themselves and secreted into the bloodstream, where it binds to receptors on satellite cells — the muscle stem cells responsible for fiber regeneration and growth.
When active, myostatin suppresses satellite cell differentiation and protein synthesis, keeping muscle size within certain physiological limits. From an evolutionary standpoint, this makes sense: excessively large muscles consume enormous amounts of energy, which would be disadvantageous in environments of food scarcity.
Loss-of-function mutations in the MSTN gene — which reduce or eliminate myostatin production — result in extraordinary muscle hypertrophy. Documented cases in humans with biallelic mutations show children with exceptional muscular development from birth, without any training intervention. In animals, deletion of the MSTN gene produces mice and cattle with double the normal muscle mass.
More relevant to the general population are common polymorphisms that reduce (without eliminating) myostatin activity. Carriers of certain variants in the MSTN promoter show lower baseline levels of circulating myostatin, resulting in greater responsiveness to strength training. A study published in the Journal of Applied Physiology (2007) identified that variants in the MSTN gene were significantly associated with the magnitude of muscle mass gain in response to 12-week resistance training programs.
IGF1 — Insulin-Like Growth Factor: The Anabolic Accelerator
The IGF1 gene (Insulin-like Growth Factor 1) encodes one of the most important anabolic hormones for muscle growth. IGF-1 is produced primarily in the liver in response to growth hormone (GH), but muscles also produce their own local isoform — MGF (Mechano Growth Factor) — in response to the mechanical stress of training.
IGF-1 promotes hypertrophy through multiple pathways:
- Activates the PI3K/Akt/mTOR pathway, the primary regulator of muscle protein synthesis
- Stimulates satellite cell proliferation and differentiation
- Inhibits myostatin activity, creating a dual pro-anabolic effect
- Reduces protein degradation by suppressing the ubiquitin-proteasome pathway
Polymorphisms in the IGF1 gene — particularly in the promoter and regulatory regions — influence baseline IGF-1 levels and the magnitude of the training response. The polymorphism rs35767 in the IGF1 promoter region, for example, is associated with variations in serum IGF-1 levels, with implications for exercise-induced hypertrophy.
A clinical trial published in the European Journal of Applied Physiology (2010) demonstrated that individuals with favorable genotypes in the IGF1 gene showed significantly greater increments in local muscle IGF-1 after strength training sessions, directly correlating with greater muscle mass gain over 16 weeks.
ACTN3 — The Fast-Twitch Fiber Protein: Sprint vs. Hypertrophy
The ACTN3 gene encodes alpha-actinin-3, a structural protein found exclusively in fast-twitch muscle fibers (type II). These fibers are primarily responsible for producing explosive force and, not coincidentally, are the ones that hypertrophy most in response to resistance training.
The R577X polymorphism (rs1815739) is one of the most studied variants in sports genetics. The X allele introduces a premature stop codon, resulting in complete absence of the alpha-actinin-3 protein in the muscles. Approximately 18% of the world's population is homozygous for the X allele (XX genotype), meaning their muscles produce no alpha-actinin-3.
Studies in elite athletes show that the RR genotype (functional alpha-actinin-3 in both alleles) is significantly more prevalent among sprinters and strength athletes than in the general population. RR carriers tend to have a higher proportion of type II fibers, greater muscle power, and — in resistance training contexts — a greater potential for fast-fiber hypertrophy.
Carriers of the XX genotype, on the other hand, show muscular adaptations more oriented toward aerobic efficiency — with type II fibers functioning more like type I fibers — which favors endurance sports performance but limits explosive hypertrophy potential.
IL15RA — The Interleukin-15 Receptor: Hypertrophy Signaler
Interleukin-15 (IL-15) is a myokine — produced by muscles during exercise — with potent anabolic effects. The IL15RA gene encodes the IL-15 alpha receptor, which determines muscle tissue's sensitivity to this signal.
IL-15 promotes muscle protein synthesis, inhibits myostatin-mediated atrophy, and stimulates satellite cell proliferation. Variants in the IL15RA gene that increase receptor expression or its affinity for IL-15 are associated with a greater hypertrophic response to strength training.
A study published in the Journal of Applied Physiology (2006) identified that the polymorphism rs2228059 in the IL15RA gene was significantly associated with muscle mass gain in women undergoing 10 weeks of resistance training. Carriers of the A allele at this polymorphism showed 2.3-fold greater quadriceps muscle mass gains than carriers of the G allele, despite identical training programs.
| Gene | Protein / Function | Relevant Variant | Impact on Hypertrophy |
|---|---|---|---|
| MSTN | Myostatin — muscle growth inhibitor | Promoter variants (lower expression) | Lower myostatin levels = greater muscle gain potential |
| IGF1 | IGF-1 — anabolic hormone, activates mTOR | rs35767 (promoter region) | Greater local IGF-1 response to exercise = greater protein synthesis |
| ACTN3 | Alpha-actinin-3 — structural in fast-twitch fibers | R577X (rs1815739) — RR/RX vs. XX genotypes | RR genotype favors type II fibers and explosive strength hypertrophy |
| IL15RA | IL-15 receptor — sensitivity to anabolic myokine | rs2228059 (A allele) | Greater IL-15 sensitivity = enhanced hypertrophic response to training |
| VDR | Vitamin D receptor — modulates strength and muscle function | BsmI, FokI (common polymorphisms) | Variants affect calcium uptake efficiency and contractile function |
The mTOR Pathway: Where Genetics and Training Meet
Regardless of the specific gene, all hypertrophy pathways converge at one central point: the mTOR pathway (mechanistic Target of Rapamycin). mTORC1 is the master regulator of muscle protein synthesis — when activated, it orchestrates the translation of new ribosomes and the production of contractile proteins such as actin and myosin.
Individual sensitivity of the mTOR pathway to resistance training is partly determined by genetic variants in genes that regulate its activators (IGF-1, amino acids, mechanical load) and inhibitors (myostatin, AMPK in catabolic contexts). Individuals with genotypes that favor mTOR activation and suppress its inhibitors have a wider and longer-lasting anabolic window following training.
"The magnitude of resistance training-induced muscle hypertrophy is highly variable between individuals and is substantially explained by genetic differences in anabolic signaling, muscle fiber composition, and the neuroendocrine response to exercise." — Medicine & Science in Sports & Exercise, 2017
Practical Implications: How to Use This Information
Knowing your hypertrophy-related genetic profile is neither a free pass to success nor a sentence of failure — it is a map for optimization. Regardless of genotype, all muscles respond to strength training; what changes is the speed, magnitude, and ideal type of stimulus.
For Genetically Advantaged Profiles
- Moderate-to-high volume works well: Muscles with high anabolic sensitivity respond well to 15–20 sets per muscle group per week
- Strength periodization is an ally: Work in the 1–6 rep range maximizes type II fiber recruitment, especially for RR genotype ACTN3 carriers
- Efficient recovery: Shorter rest windows between sessions may be tolerated due to greater regenerative capacity
For Profiles with Lower Genetic Responsiveness
- Consistency beats isolated intensity: Sustained linear progression over years outperforms any short-term genetic advantage
- Focus on technique and time under tension: Slow eccentric contractions (4–6 seconds) maximize mechanical damage and the growth signal regardless of genotype
- Precise nutrition is more critical: The post-workout anabolic window should be exploited with high biological value protein (1.6–2.2 g/kg/day) and carbohydrates to optimize IGF-1 signaling
- Sleep is non-negotiable: The GH and IGF-1 peak occurs during deep sleep — compromising sleep means compromising muscle growth
What helixXY Can Reveal
The helixXY genetic report analyzes variants in the key genes associated with hypertrophy and muscle composition, translating genomic data into practical guidance for your training and nutrition.
Based on your individual profile, helixXY can reveal:
- Your genotype at ACTN3 R577X — indicating whether your fiber composition favors strength/hypertrophy or endurance/stamina training
- Variants in the MSTN gene that influence your baseline myostatin levels and, therefore, your genetic "ceiling" for muscle mass
- Polymorphisms in IGF1 that modulate your anabolic response to resistance training
- Your genetic sensitivity to IL-15 via the IL15RA receptor, indicating whether you are a "hyper-responder" or "hypo-responder" to strength training
- Variants in the VDR gene that affect muscle function efficiency and calcium uptake by fibers
This information, combined with your training history and goals, allows fitness professionals to personalize training volume, intensity, frequency, and methods in a truly individualized way — eliminating the frustrating cycle of trying generic programs that work for others but not for you.
Important: helixXY reports are informational and educational. Consult a healthcare professional before making significant changes to your training program, especially if you have pre-existing health conditions.
References
- Pescatello LS et al. Highlights from the functional single nucleotide polymorphisms associated with human muscle size and strength or FAMuSS study. BioMed Research International. 2013.
- Walsh S et al. The ACTN3 genotype is associated with human elite athletic performance. American Journal of Human Genetics. 2003.
- Roth SM et al. The insulin-like growth factor 1 gene and its involvement in skeletal muscle aging. Journal of Applied Physiology. 2010.
- Pistilli EE et al. Interleukin-15 and interleukin-15Rα SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Journal of Applied Physiology. 2006.
- Schuelke M et al. Myostatin mutation associated with gross muscle hypertrophy in a child. New England Journal of Medicine. 2004.
